Company Growth (employees)
Biogen was founded in 1978 and is headquartered in Cambridge, US
Key People at Biogen
Michel Vounatsos
CEO
Walter Charles
Chief Procurement Officer
Biogen Office Locations
Biogen has an office in Cambridge
Cambridge, US (HQ)
225 Binney St
Biogen Data and Metrics
Biogen Financial Metrics
Biogen's revenue was reported to be $11.4 b in FY, 2016 which is a 6% increase from the previous period.
$, USD
Revenue (FY, 2016) | 11.4 b |
Revenue growth (FY, 2015 - FY, 2016), % | 6% |
Net income (FY, 2016) | 3.7 b |
EBIT (FY, 2016) | 5.2 b |
Market capitalization (23-Jun-2017) | 59.5 b |
Closing share price (23-Jun-2017) | 280.6 |
Cash (31-Dec-2016) | 2.3 b |
Biogen's current market capitalization is $59.5 b.
- Source: Company Filings
| $, USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Revenue | 6.9 b | 9.7 b | 10.8 b | 11.4 b |
Revenue growth, % | 40% | 11% | 6% | |
EBIT | 4.9 b | 5.2 b | ||
EBIT margin, % | 45% | 45% | ||
Net Income | 1.9 b | 2.9 b | 3.6 b | 3.7 b |
- Source: Company Filings
| $, USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Cash | 602.6 m | 1.2 b | 1.3 b | 2.3 b |
Accounts Receivable | 824.4 m | 1.3 b | 1.2 b | 1.4 b |
Inventories | 659 m | 804 m | 893.4 m | 1 b |
Current Assets | 3.2 b | 4.7 b | 6.7 b | 8.7 b |
PP&E | 1.8 b | 1.8 b | 2.2 b | 2.5 b |
Goodwill | 1.2 b | 1.8 b | 2.7 b | 3.7 b |
Total Assets | 11.9 b | 14.3 b | 19.5 b | 22.9 b |
Accounts Payable | 219.9 m | 229.2 m | 267.4 m | 279.8 m |
Total Debt | 1.2 b | |||
Current Liabilities | 1.8 b | 2.2 b | 2.6 b | 3.4 b |
Additional Paid-in Capital | 4 b | 4.2 b | ||
Retained Earnings | 6.3 b | 9.3 b | 12.2 b | 15.1 b |
Total Equity | 8.6 b | 10.8 b | 9.4 b | 12.1 b |
Debt to Equity Ratio | 0.1 x | |||
Debt to Assets Ratio | 0.1 x | |||
Financial Leverage | 1.4 x | 1.3 x | 2.1 x | 1.9 x |
| $, USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Net Income | 1.9 b | 2.9 b | 3.6 b | 3.7 b |
Depreciation and Amortization | 688.2 m | 600.4 m | 682.7 m | |
Accounts Receivable | (130 m) | (510 m) | 29 m | (240 m) |
Inventories | (240 m) | (190 m) | (170 m) | (170 m) |
Purchases of PP&E | (246.3 m) | (287.8 m) | (643 m) | (616.1 m) |
Cash From Investing Activities | (1.6 b) | (1.5 b) | (4.6 b) | (2.5 b) |
Cash From Financing Activities | (716.5 m) | (755.9 m) |
| $, USD | Y, 2016 |
|---|---|
Revenue/Employee | 1.6 m |
Financial Leverage | 1.9 x |
Biogen Operating Metrics
Biogen's Training Provided, no. of people was reported to be 40 k in FY, 2016
- Source: SEC Filings
Biogen Market Value History
Biogen Median Salaries
Source: 109 public H-1B filings from Biogen
